Hydrogen sulfide differentially affects the hepatic vasculature in response to phenylephrine and endothelin 1 during endotoxemia

Shock

Volumn 39, Issue 2, 2013, Pages 168-175

  Norris, Eric J ^a   Larion, Sebastian ^a   Culberson, Catherine R ^a   Clemens, Mark G ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

endothelin; Endotoxin; hydrogen sulfide; liver; microcirculation

Indexed keywords

CARBON MONOXIDE; CATECHOLAMINE; ENDOTHELIN 1; ENDOTOXIN; HYDROGEN SULFIDE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHENYLEPHRINE; PROPARGYLGLYCINE;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; ENDOTOXEMIA; LIVER CIRCULATION; MALE; MICROCIRCULATION; NONHUMAN; OXYGEN CONSUMPTION; PATIENT MONITORING; PORTAL VEIN BLOOD PRESSURE; RAT; SEPSIS; VASCULAR RESISTANCE; VASOCONSTRICTION;

ANIMALS; ENDOTHELIN-1; ENDOTOXEMIA; HYDROGEN SULFIDE; LIPOPOLYSACCHARIDES; LIVER; MALE; MICROCIRCULATION; OXYGEN CONSUMPTION; PHENYLEPHRINE; PORTAL PRESSURE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 84872971185     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182736688     Document Type: Article

References (48)

1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554, 2003.
2. Ince C: The microcirculation is the motor of sepsis. Crit Care 9(Suppl 4): S13-S19, 2005.
3. Pastor CM, Billiar TR: Nitric oxide causes hyporeactivity to phenylephrine in isolated perfused livers from endotoxin-treated rats. Am J Physiol 268: G177-G182, 1995.
4. Pannen BH, Bauer M, Zhang JX, Robotham JL, Clemens MG: Endotoxin pretreatment enhances portal venous contractile response to endothelin-1. Am J Physiol 270:H7-H15, 1996.
5. Baveja R, Yokoyama Y, Korneszczuk K, Zhang JX, Clemens MG: Endothelin 1 impairs oxygen delivery in livers from LPS-primed animals. Shock 17:383-388, 2002.
6. Baveja R, Kresge N, Ashburn JH, Keller S, Yokoyama Y, Sonin N, Zhang JX, Huynh T, Clemens MG: Potentiated hepatic microcirculatory response to endothelin-1 during polymicrobial sepsis. Shock 18:415-422, 2002.
7. Stipanuk MH, Beck PW: Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J 206:267-277, 1982.
8. Bukovska G, Kery V, Kraus JP: Expression of human cystathionine beta-synthase in Escherichia coli: purification and characterization. Protein Expr Purif 5:442-448, 1994.
9. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, Kimura H: 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 11:703-714, 2009.
10. Zhang H, Zhi L, Moore PK, Bhatia M: Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol 290:L1193-L1201, 2006.
11. Zhao W, Zhang J, Lu Y, Wang R: The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 20:6008-6016, 2001.
12. Hosoki R, Matsuki N, Kimura H: The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237:527-531, 1997.
13. Ali MY, Ping CY, Mok YY, Ling L, Whiteman M, Bhatia M, Moore PK: Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol 149:625-634, 2006.
14. Lim JJ, Liu YH, Khin ES, Bian JS: Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells. Am J Physiol Cell Physiol 295:C1261-C1270, 2008.
15. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322:587-590, 2008.
16. 2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology 42: 539-548, 2005.
17. Nishida J, McCuskey RS, McDonnell D, Fox ES: Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 267:G1135-G1141, 1994.
18. Keller SA, Paxian M, Ashburn JH, Clemens MG, Huynh T: Kupffer cell ablation improves hepatic microcirculation after trauma and sepsis. J Trauma 58:740-749; discussion 749-751, 2005.
19. Zhang, JX, Pegoli W Jr, Clemens MG: Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 266:G624-G632, 1994.
20. Kawada N, Tran-Thi TA, Klein H, Decker K: The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 213:815-823, 1993.
21. Housset C, Rockey DC, Bissell DM: Endothelin receptors in rat liver: lip-ocytes as a contractile target for endothelin 1. Proc Natl Acad Sci USA 90: 9266-9270, 1993.
22. Kamoun WS, Shin MC, Karaa A, Clemens MG: Quantification of hepatic microcirculation heterogeneity of perfusion: effects of endothelin-1. Microvasc Res 69:180-186, 2005.
23. Paxian M, Keller SA, Cross B, Huynh TT, Clemens MG: High-resolution visualization of oxygen distribution in the liver in vivo. Am J Physiol Gastrointest Liver Physiol 286:G37-G44, 2004.
24. Bauer M, Zhang JX, Bauer I, Clemens MG: ET-1 induced alterations of hepatic microcirculation: sinusoidal and extrasinusoidal sites of action. Am J Physiol 267:G143-G149, 1994.
25. Bauer M, Bauer I, Sonin NV, Kresge N, Baveja R, Yokoyama Y, Harding D, Zhang JX, Clemens MG: Functional significance of endothelin B receptors in mediating sinusoidal and extrasinusoidal effects of endothelins in the intact rat liver. Hepatology 31:937-947, 2000.
26. Rockey DC, Weisiger RA: Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology 24:233-240, 1996.
27. Sugano T, Suda K, Shimada M, Oshino N: Biochemical and ultrastructural evaluation of isolated rat liver systems perfused with a hemoglobin-free medium. J Biochem 83:995-1007, 1978.
28. Norris EJ, Culberson CR, Narasimhan S, Clemens MG: The liver as a central regulator of hydrogen sulfide. Shock 36:242-250, 2011.
29. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabo C, Sellke FW: The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg 33: 906-913, 2008.
30. Kang K, Zhao M, Jiang H, Tan G, Pan S, Sun X: Role of hydrogen sulfide in hepatic ischemia-reperfusionYinduced injury in rats. Liver Transpl 15: 1306-1314, 2009.
31. Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M, Moore PK: Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 19:1196-1198, 2005.
32. Ayala A, Perrin MM, Wang P, Chaudry IH: Sepsis induces an early increased spontaneous release of hepatocellular stimulatory factor (interleukin-6) by Kupffer cells in both endotoxin tolerant and intolerant mice. J Surg Res 52: 635-641, 1992.
33. Wang P, Chaudry IH: Mechanism of hepatocellular dysfunction during hyper-dynamic sepsis. Am J Physiol 270:R927-R938, 1996.
34. Oda M, Yokomori H, Han JY: Regulatory mechanisms of hepatic micro-circulation. Clin Hemorheol Microcirc 29:167-182, 2003.
35. Hollenberg SM, Easington CR, Osman J, Broussard M, Parrillo JE: Effects of nitric oxide synthase inhibition on microvascular reactivity in septic mice. Shock 12:262-267, 1999.
36. Hui Y, Du J, Tang C, Bin G, Jiang H: Changes in arterial hydrogen sulfide (H(2)S) content during septic shock and endotoxin shock in rats. J Infect 47: 155-160, 2003.
37. Alam I, Bass NM, Bacchetti P, Gee L, Rockey DC: Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites. Am J Gastroenterol 95:199-203, 2000.
38. Kwok W, Lee SH, Culberson C, Korneszczuk K, Clemens MG: Caveolin-1 mediates endotoxin inhibition of endothelin-1Yinduced endothelial nitric oxide synthase activity in liver sinusoidal endothelial cells. Am J Physiol Gastrointest Liver Physiol 297:G930-G939, 2009.
39. Merkel SM, Kamoun W, Karaa A, Korneszczuk K, Schrum LW, Clemens MG: LPS inhibits endothelin-1Ymediated eNOS translocation to the cell membrane in sinusoidal endothelial cells. Microcirculation 12:433-442, 2005.
40. Paxian M, Keller SA, Baveja R, Korneszczuk K, Huynh TT, Clemens MG: Functional link between ETB receptors and eNOS maintain tissue oxygenation in the normal liver. Microcirculation 11:435-449, 2004.
41. Quayle JM, Nelson MT, Standen NB: ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77:1165-1232, 1997.
42. Tang G, Wu L, Liang W, Wang R: Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol 68:1757-1764, 2005.
43. Distrutti E, Mencarelli A, Santucci L, Renga B, Orlandi S, Donini A, Shah V, Fiorucci S: The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. Hepatology 47: 659-667, 2008.
44. van de Bovenkamp M, Groothuis GM, Draaisma AL, Merema MT, Bezuijen JI, van Gils MJ, Meijer DK, Friedman SL, Olinga P: Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu. Toxicol Sci 85:632-638, 2005.
45. Lee ZW, Zhou J, Chen CS, Zhao Y, Tan CH, Li L, Moore PK, Deng LW: The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS One 6:e21077, 2011.
46. Reinehr R, Fischer R, Haussinger D: Regulation of endothelin-A receptor sensitivity by cyclic adenosine monophosphate in rat hepatic stellate cells. Hepatology 36:861-873, 2002.
47. Whiteman M, Li L, Kostetski I, Chu SH, Siau JL, Bhatia M, Moore PK: Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun 343: 303-310, 2006.
48. 2+ oscillations, and activation of glyco-genolysis. J Clin Invest 87:133-138, 1991.